Related Experiment Video
Updated: Jun 13, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Severe Acute Porphyria Exacerbation Post Intravenous Iron Infusion: A Case Report.
Tarek Hammad1, Sayeed Hossain2, Tanweer Ahmad3
1Department of Cardiology, Northampton General Hospital NHS Trust, Northampton, GBR.
Intravenous iron infusions can acutely worsen erythropoietic porphyria (EPP), a rare genetic disorder. Prompt diagnosis, multidisciplinary care, and avoiding triggers like iron are crucial for managing EPP symptoms.
Area of Science:
- Biochemistry
- Genetics
- Dermatology
Background:
- Erythropoietic porphyria (EPP) is a rare inherited disorder affecting heme synthesis.
- Patients with EPP are sensitive to sunlight, experiencing severe skin reactions.
- Triggers for EPP exacerbations require careful identification.
Observation:
- A 28-year-old male with EPP experienced acute symptom exacerbation following an intravenous iron infusion.
- Symptoms included a vesicular rash, severe itching, nausea, vomiting, and abnormal liver function tests.
Findings:
- Intravenous iron administration can act as a trigger for severe EPP exacerbations.
- Multidisciplinary care involving dermatology, gastrointestinal, and hematology specialists is vital for effective management.
Implications:
- Vigilance in identifying trigger factors like iron infusions is critical for EPP patient management.
- Prompt diagnosis, light avoidance, and genetic counseling are essential components of EPP care.
- Successful management leads to symptom resolution and return to normal activities.
More Related Videos
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
09:02Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Related Concept Videos
Prevention of Further Absorption of Poison
Vitamins
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Acute Pancreatitis II: Clinical Manifestations and Management
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...